PSS10 Cost- Effectiveness of Ranibizumab in Patients with Neovascular Wet Age-Related Macular Degeneration (Namd) at the Mexican Social Security System (Imss)
Abstract
Authors
H. Arreola-Ornelas A. Rosado-Buzzo L. García-Mollinedo J. Dorantes-Aguilar E. Lemus-Carmona